...
首页> 外文期刊>Medical oncology >Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.
【24h】

Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.

机译:p16,p15,MGMT和DAPK基因表观遗传失活对滤泡性淋巴瘤的预后意义。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, methylation-specific polymerase chain reaction was used to investigate the role and potential prognostic significance of the methylation status of p16, p15, MGMT and DAPK genes in 32 specimens of follicular lymphoma (FL). Hypermethylation of p15 gene was associated with lower hemoglobin level (P = 0.020) and MGMT/DAPK comethylation with relapsed disease (P = 0.018). Among all patients with FL, there was no significant difference in the overall survival between those with hypermethylated and unmethylated of any examined genes. Therefore, we analyzed methylation in the different groups according to FL International Prognostic Index (FLIPI) and tumor grade. In the high-risk group, patients with hypermethylated p16 gene had significant lower overall survival than those with unmethylated p16 (P = 0.006) and trend toward shorter failure-free survival (P = 0.068). In the same risk group, there was a trend toward longer overall survival for patients with hypermethylated MGMT gene, compared to those with unmethylated MGMT gene (P = 0.066). p15 methylation had impact on shorter overall survival in grade I group of patients (P = 0.013), and DAPK methylation tended to have impact on shorter failure-free survival in the whole examined group (P = 0.079). Our results suggest that promoter methylation of p16 and MGMT genes could have prognostic value when used in combination with the FLIPI and p15 methylation in combination with tumor grade. Concurrent methylation of MGMT and DAPK genes could be the marker of tumor chemoresistance and disease recurrence.
机译:在这项研究中,甲基化特异性聚合酶链反应用于研究32例滤泡性淋巴瘤(FL)标本中p16,p15,MGMT和DAPK基因的甲基化状态的作用和潜在的预后意义。 p15基因的高甲基化与较低的血红蛋白水平(P = 0.020)和MGMT / DAPK共甲基化与复发性疾病相关(P = 0.018)。在所有FL患者中,任何检查基因的高甲基化和未甲基化患者的总生存率均无显着差异。因此,我们根据FL国际预后指数(FLIPI)和肿瘤等级分析了不同组的甲基化。在高风险组中,与未甲基化的p16基因相比,具有高甲基化的p16基因患者的总生存期显着降低(P = 0.006),并且倾向于无故障生存期缩短(P = 0.068)。在同一风险组中,与未甲基化的MGMT基因相比,具有高甲基化的MGMT基因的患者有更长的总生存期的趋势(P = 0.066)。在I级患者中,p15甲基化对较短的总生存有影响(P = 0.013),而在整个检查组中DAPK甲基化往往对较短的无衰竭生存有影响(P = 0.079)。我们的结果表明,当与FLIPI结合使用时,p16和MGMT基因的启动子甲基化可能具有预后价值;与肿瘤分级结合使用时,p15甲基化可能具有预后价值。 MGMT和DAPK基因同时甲基化可能是肿瘤化学耐药性和疾病复发的标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号